Lipid Metabolism Practice Questions

Q: A newborn presents with craniofacial abnormalities, severely reduced muscle tone, and seizures. Biochemical analysis reveals elevated very long chain fatty acids in serum. What is the most likely underlying cause?

Peroxisomal biogenesis defect. ***Peroxisomal biogenesis defect*** - The classic presentation of **Zellweger syndrome**, a peroxisomal biogenesis disorder, includes craniofacial abnormalities (e.g., high forehead, large anterior fontanelle), profound hypotonia, and seizures in the neonatal period. - This condition is caused by mutations in **PEX genes**, leading to the absence of functional peroxisomes and the subsequent **accumulation of very long chain fatty acids (VLCFAs)** in the serum. *Mitochondrial inheritance* - Mitochondrial disorders typically present with symptoms such as lactic acidosis, myopathy, or encephalopathy, but they do not specifically cause the elevation of VLCFAs. - Inherited via **maternal lineage**, these defects usually involve defects in the electron transport chain rather than fatty acid oxidation pathways. *Lysosomal storage disorder* - These disorders are characterized by the accumulation of substrates due to deficient enzymes within lysosomes, as seen in conditions like Gaucher or Tay-Sachs disease. - They generally present with progressive organomegaly (e.g., hepatosplenomegaly) and neurodegeneration rather than the characteristic craniofacial dysmorphism and VLCFA elevation seen in peroxisomal defects. *Simultaneously activate multiple tumor suppressor genes* - This is not a mechanism related to metabolic storage diseases or peroxisomal function. - Tumor suppressor gene activation is a concept associated with cancer genetics and abnormal cell growth, not metabolic enzyme deficiencies.

Q: Elevated serum triglyceride levels are observed in all of the following conditions EXCEPT:

Abetalipoproteinemia. ***Abetalipoproteinemia*** - In this rare disorder, there is a **deficiency of apolipoprotein B**, preventing the formation and secretion of **chylomicrons**, VLDL, and LDL. - Consequently, individuals with this condition have **very low levels of serum triglycerides** and cholesterol rather than elevated levels. *Type 2 diabetes mellitus* - Insulin resistance leads to **decreased activity of lipoprotein lipase (LPL)**, the enzyme responsible for clearing triglycerides from the blood. - Increased hepatic production of **VLDL** is also typically present, leading to **hypertriglyceridemia**. *High fructose diet* - Fructose metabolism bypasses the rate-limiting step of glycolysis (PFK-1), leading to an **excess of Acetyl-CoA** in the liver. - This excess substrate promotes the synthesis of **fatty acids and VLDL**, which are subsequently secreted into the blood, raising **triglyceride levels**. *Nephrotic syndrome* - The loss of albumin in the urine triggers an **increase in hepatic lipoprotein synthesis** as a compensatory mechanism to maintain oncotic pressure. - Additionally, the urinary loss of regulatory proteins leads to **decreased catabolism of lipoproteins**, resulting in **hyperlipidemia**, predominantly involving triglycerides and LDL.

Q: Reverse cholesterol transport is mediated by which lipoprotein?

HDL. **Explanation:** **Reverse Cholesterol Transport (RCT)** is the physiological process by which excess cholesterol is removed from peripheral tissues (like macrophages in the arterial wall) and transported back to the liver for excretion in bile. **HDL (High-Density Lipoprotein)** is the primary mediator of this process, which is why it is clinically referred to as "Good Cholesterol." The process involves: 1. **Efflux:** Free cholesterol is moved from cells to nascent HDL via **ABCA1 transporters**. 2. **Esterification:** The enzyme **LCAT** (Lecithin-Cholesterol Acyltransferase) converts free cholesterol into cholesterol esters, trapping them in the HDL core. 3. **Hepatic Uptake:** HDL delivers these esters to the liver via **SR-BI receptors** or transfers them to other lipoproteins via **CETP**. **Why other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Synthesized in the liver to transport endogenous triglycerides to peripheral tissues. * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol," it transports cholesterol **from** the liver **to** peripheral tissues. High levels are associated with atherosclerosis. * **IDL (Intermediate-Density Lipoprotein):** A transient product formed during the conversion of VLDL to LDL; it is not involved in RCT. **High-Yield NEET-PG Pearls:** * **Apo A-I:** The major apoprotein associated with HDL and a potent activator of LCAT. * **Tangier Disease:** A genetic deficiency of ABCA1 transporters resulting in extremely low HDL levels and orange-colored tonsils. * **Anti-atherogenic property:** HDL prevents foam cell formation, reducing the risk of Coronary Artery Disease (CAD).

Q: Which lipoprotein has the highest concentration of endogenous triglycerides?

VLDL (Very-low-density lipoprotein). **Explanation:** The core of this question lies in distinguishing between **exogenous** and **endogenous** lipid transport. **Why VLDL is correct:** VLDL (Very-low-density lipoprotein) is synthesized in the **liver**. Its primary physiological role is to transport **endogenous triglycerides** (lipids synthesized by the body) from the liver to peripheral tissues. It contains approximately 50-60% triglycerides by weight, making it the lipoprotein with the highest concentration of triglycerides of internal origin. **Why the other options are incorrect:** * **Chylomicrons:** While chylomicrons have the highest *overall* triglyceride content (85-90%), these are **exogenous** (dietary) triglycerides absorbed from the intestines. The question specifically asks for endogenous sources. * **LDL:** Known as the primary carrier of **cholesterol** to peripheral tissues. It is a metabolic byproduct of VLDL (via IDL) and has a low triglyceride concentration. * **HDL:** Known as "good cholesterol," it is involved in **reverse cholesterol transport** (carrying cholesterol from tissues back to the liver). It has the highest protein content and the lowest lipid content. **High-Yield Clinical Pearls for NEET-PG:** * **Apolipoprotein Marker:** B-100 is the characteristic apolipoprotein for VLDL and LDL, while B-48 is unique to Chylomicrons. * **Rate-limiting enzyme:** HMG-CoA reductase is the rate-limiting enzyme for endogenous cholesterol synthesis (target of Statins). * **Lipoprotein Lipase (LPL):** This enzyme, located on capillary endothelium, is responsible for clearing triglycerides from both Chylomicrons and VLDL. * **Friedewald Equation:** LDL = Total Cholesterol – HDL – (Triglycerides/5). Note: This is invalid if TG >400 mg/dL.

Q: Which lipoprotein has the highest quantity of lipid and the lowest concentration of protein?

Chylomicrons. ### Explanation Lipoproteins are classified based on their **density**, which is determined by the ratio of lipids to proteins. Since lipids have a lower density than water and proteins have a higher density, the lipoprotein with the most lipid and least protein will be the least dense. **1. Why Chylomicrons are correct:** Chylomicrons are the largest and least dense of all lipoproteins. They consist of approximately **98-99% lipid** (predominantly exogenous triglycerides) and only **1-2% protein**. Because they have the highest lipid-to-protein ratio, they float to the top when plasma is left standing, forming a creamy supernate. **2. Analysis of Incorrect Options:** * **VLDL (Very Low Density Lipoproteins):** These are the second least dense. They contain about 90% lipid (mainly endogenous triglycerides) and 10% protein. * **LDL (Low Density Lipoproteins):** Known as "bad cholesterol," they contain about 75-80% lipid (primarily cholesterol) and 20-25% protein. * **HDL (High Density Lipoproteins):** Known as "good cholesterol," these are the smallest and densest. They have the **highest concentration of protein** (approx. 40-55%) and the lowest quantity of lipid. **3. High-Yield NEET-PG Pearls:** * **Electrophoretic Mobility:** On electrophoresis (pH 8.6), the order of mobility from origin to anode is: **Chylomicrons (Origin) < LDL (Beta) < VLDL (Pre-beta) < HDL (Alpha).** Note that VLDL moves faster than LDL despite being less dense. * **Apolipoprotein Markers:** * Chylomicrons: **Apo B-48** (unique marker). * VLDL/IDL/LDL: **Apo B-100**. * HDL: **Apo A-I** (activates LCAT). * **Function:** Chylomicrons transport **exogenous** (dietary) triglycerides, whereas VLDL transports **endogenous** triglycerides from the liver.

Question 1

A newborn presents with craniofacial abnormalities, severely reduced muscle tone, and
seizures. Biochemical analysis reveals elevated very long chain fatty acids in serum. What is the
most likely underlying cause?

Accepted Answer

Peroxisomal biogenesis defect

Answer

Mitochondrial inheritance

Answer

Lysosomal storage disorder

Answer

Simultaneously activate multiple tumor suppressor genes

Question 2

Elevated serum triglyceride levels are observed in all of the following conditions EXCEPT:

Accepted Answer

Abetalipoproteinemia

Answer

Type 2 diabetes mellitus

Answer

High fructose diet

Answer

Nephrotic syndrome

Question 3

Reverse cholesterol transport is mediated by which lipoprotein?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

IDL

Question 4

Which lipoprotein has the highest concentration of endogenous triglycerides?

Accepted Answer

VLDL (Very-low-density lipoprotein)

Answer

Chylomicrons

Answer

LDL (Low-density lipoprotein)

Answer

HDL (High-density lipoprotein)

Question 5

Which lipoprotein has the highest quantity of lipid and the lowest concentration of protein?

Accepted Answer

Chylomicrons

Answer

Very low density lipoproteins

Answer

Low density lipoproteins

Answer

High density lipoproteins

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?